文献速递心境障碍

细胞封装增强间充质干细胞抗抑郁效应并改善难治性抑郁大鼠行为

Cell encapsulation enhances antidepressant effect of the mesenchymal stem cells and counteracts depressive-like behavior of treatment-resistant depressed rats.
PubMed 文献 · Mol Psychiatry · 2018-08-14

该研究在Wistar Kyoto(WKY)大鼠(难治性抑郁动物模型)中探讨封装间充质干细胞(eMSCs)的疗效。侧脑室植入eMSCs可抵消抑郁样行为并增强室下区(SVZ)与海马齿状回(DG)的内源性神经发生,而未封装MSCs或纹状体植入eMSCs无此效应。eMSCs稳定分泌VEGF、BDNF、FGF-2和CNTF并激活相关通路,提示其抗抑郁效应可能经神经发生途径介导。

要点

  • 侧脑室植入封装MSCs可改善WKY大鼠抑郁样行为并增强SVZ与DG神经发生。
  • 未封装MSCs或纹状体植入eMSCs未显示上述改善效应,提示封装与植入部位均重要。
  • eMSCs稳定分泌VEGF、BDNF、FGF-2、CNTF并上调VEGF、CNTF及其受体表达。

核心结论

  • 侧脑室植入封装间充质干细胞在难治性抑郁模型大鼠中发挥抗抑郁效应,可能经神经发生相关通路介导。

研究设计与样本

  • 研究采用Wistar Kyoto(WKY)大鼠作为难治性抑郁动物模型,比较封装MSCs(eMSCs)与未封装MSCs及不同植入部位的效应。

主要发现

  • 侧脑室植入eMSCs抵消WKY大鼠抑郁样行为,并增强SVZ与海马DG的内源性神经发生。
  • 未封装MSCs植入或eMSCs植入纹状体均未显示上述改善效应。
  • eMSCs稳定分泌VEGF、BDNF、FGF-2和CNTF,侧脑室植入激活相关生长因子通路并上调VEGF、CNTF及其受体表达。

临床怎么用

  • 结果为动物实验证据,提示封装MSCs经侧脑室植入可能成为难治性抑郁的潜在治疗策略,尚需临床验证。

局限性

  • 研究仅基于WKY大鼠模型,原文未报告样本量、效应量及统计细节,向临床转化仍需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Despite the advances in pharmacological therapies, only the half of depressed patients respond to currently available treatment. Thus, the need for further investigation and development of effective therapies, especially those designed for treatment-resistant depression, has been sorely needed. Although antidepressant effects of mesenchymal stem cells (MSCs) have been reported, the potential benefit of this cell therapy on treatment-resistant depression is unknown. Cell encapsulation may enhance the survival rate of grafted cells, but the therapeutic effects and mechanisms mediating encapsulation of MSCs remain unexplored. Here, we showed that encapsulation enhanced the antidepressant effects of MSCs by attenuating depressive-like behavior of Wistar Kyoto (WKY) rats, which are considered as a promising animal model of treatment-resistant depression. The implantation of encapsulated MSCs (eMSCs) into the lateral ventricle counteracted depressive-like behavior and enhanced the endogenous neurogenesis in the subventricular zone (SVZ) and the dentate gyrus (DG) of the hippocampus, whereas the implantation of MSCs without encapsulation or the implantation of eMSCs into the striatum did not show such ameliorative effects. eMSCs displayed robust and stable secretion of vascular endothelial growth factor (VEGF), brain-derived neurotrophic factor, fibroblast growth factor-2, and ciliary neurotrophic factor (CNTF), and the implantation of eMSCs into the lateral ventricle activated relevant pathways associated with these growth factors. Additionally, eMSCs upregulated intrinsic expression of VEGF and CNTF and their receptors. This study suggests that the implantation of eMSCs into the lateral ventricle exerted antidepressant effects likely acting via neurogenic pathways, supporting their utility for depression treatment.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Kin K, Yasuhara T, Kameda M, et al. Cell encapsulation enhances antidepressant effect of the mesenchymal stem cells and counteracts depressive-like behavior of treatment-resistant depressed rats. Mol Psychiatry. 2018. PMID: 30108315. doi:10.1038/s41380-018-0208-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。